Robert Page
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Page has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Alison Blazey
Faculty of Medicine and Health The University of Sydney Sydney Australia
1 shared publication- Amanda Roxburgh
Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Frankston, VIC, Australia; Disease Elimination, Burnet Institute, Melbourne, VIC, Australia
1 shared publication - Amy Healey
St Vincent's Clinical School Faculty of Medicine, UNSW Sydney Sydney Australia
1 shared publication - Amy Peacock
National Drug and Alcohol Research Centre UNSW Sydney Sydney Australia
1 shared publication Charlotte Ismay
Drug and Alcohol Clinical Services Hunter New England Local Health District Newcastle Australia
1 shared publication- Chris Tremonti
Alcohol and Drug Services St Vincent's Hospital Sydney Australia
1 shared publication
Latest Publications
- 22 July 2026
- Published by Wiley in Drug and Alcohol Review
- Vol. 45 (5)
Patient Experience of Withdrawal During Methadone–Buprenorphine Transfer: A Prospective Cohort Study
Introduction: Methadone‐to‐buprenorphine transfers (MBT) are increasingly common as buprenorphine use expands. Evidence describing patient experience of withdrawal during MBT in real‐world populations is limited. This study aimed to characterise withdrawal trajectories during MBT and examine whether psychosocial and clinical factors influence the severity or timing of withdrawal. Methods: This analysis used data from a prospective, non‐randomised clinical trial comparing low‐dose and stop‐and‐start MBT techniques ( n = 117). Covariates included methadone dose, duration on methadone, transfer setting, study arm, withdrawal expectancy, psychological distress, substance use and unstable housing. Withdrawal was assessed daily using the Clinical Opioid Withdrawal Scale (COWS) and Short Opiate Withdrawal Scale. Results: Ninety‐four participants (80.3%) completed transfer. Withdrawal followed a consistent trajectory across the cohort, peaking around Day 5. Psychosocial and clinical characteristics—including unstable housing, substance use, psychological distress and methadone dose—were not associated with withdrawal severity or timing. Compared with stop‐and‐start transfer, low‐dose transfer was associated with a delayed and larger increase in objective withdrawal: peak COWS occurred 2.3 days later (95% CI 0.3–4.3) and the largest one‐day increase was 3.8 points higher (95% CI 0.5–7.0). Discussion and Conclusions: Patient factors often considered barriers to MBT were not associated with withdrawal severity or timing. Low‐dose transfer was associated with a delayed and slightly higher withdrawal peak but did not reduce overall transfer success. These findings suggest that withdrawal during MBT follows a broadly similar trajectory across patients with differing psychosocial complexity. Planning for expected withdrawal, rather than selecting patients based on perceived complexity, may be more clinically relevant.
- 22 July 2026
- Published by Wiley in Drug and Alcohol Review
- Vol. 45 (5)
Patient Experience of Withdrawal During Methadone–Buprenorphine Transfer: A Prospective Cohort Study
Introduction: Methadone‐to‐buprenorphine transfers (MBT) are increasingly common as buprenorphine use expands. Evidence describing patient experience of withdrawal during MBT in real‐world populations is limited. This study aimed to characterise withdrawal trajectories during MBT and examine whether psychosocial and clinical factors influence the severity or timing of withdrawal. Methods: This analysis used data from a prospective, non‐randomised clinical trial comparing low‐dose and stop‐and‐start MBT techniques ( n = 117). Covariates included methadone dose, duration on methadone, transfer setting, study arm, withdrawal expectancy, psychological distress, substance use and unstable housing. Withdrawal was assessed daily using the Clinical Opioid Withdrawal Scale (COWS) and Short Opiate Withdrawal Scale. Results: Ninety‐four participants (80.3%) completed transfer. Withdrawal followed a consistent trajectory across the cohort, peaking around Day 5. Psychosocial and clinical characteristics—including unstable housing, substance use, psychological distress and methadone dose—were not associated with withdrawal severity or timing. Compared with stop‐and‐start transfer, low‐dose transfer was associated with a delayed and larger increase in objective withdrawal: peak COWS occurred 2.3 days later (95% CI 0.3–4.3) and the largest one‐day increase was 3.8 points higher (95% CI 0.5–7.0). Discussion and Conclusions: Patient factors often considered barriers to MBT were not associated with withdrawal severity or timing. Low‐dose transfer was associated with a delayed and slightly higher withdrawal peak but did not reduce overall transfer success. These findings suggest that withdrawal during MBT follows a broadly similar trajectory across patients with differing psychosocial complexity. Planning for expected withdrawal, rather than selecting patients based on perceived complexity, may be more clinically relevant.
- Open Access
- 19 July 2024
- Published by Wiley in Drug and Alcohol Review
- Vol. 43 (6) , 1592-1596
The role of on‐site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need
Introduction: The Sydney Medically Supervised Injecting Centre provides a safe, non‐judgemental space where people can inject pre‐obtained substances under the supervision of trained staff. This article describes an unusual incident occurring at the Medically Supervised Injecting Centre in January 2023.Case Presentation: Two regular male clients attending the Medically Supervised Injecting Centre injected a substance they believed to be cocaine. Both clients experienced adverse reactions; one was transported to hospital, while the other became extremely distressed and agitated. Paraphernalia sent for testing returned a result of tiletamine (a dissociative used in veterinary medicine) and no cocaine, 30 h after the incident.Discussion and Conclusions: Where substances are novel or unknown, adverse events are often unexpected and may be more difficult to prepare for. Substance‐induced acute agitation can be alarming and hazardous for people consuming drugs and those around them and may pose challenges for staff. There is a substantial evidence base for the benefits of on‐site drug analysis and drug checking in reducing harms related to drug use, and in enhancing drug market monitoring. This incident was successfully managed by Medically Supervised Injecting Centre and hospital staff, with no major consequence, however clinical management could have been improved using point of care drug testing.
- 19 July 2024
- Published by Wiley in Drug and Alcohol Review
- Vol. 43 (6) , 1592-1596
Open AccessThe role of on‐site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need
Introduction: The Sydney Medically Supervised Injecting Centre provides a safe, non‐judgemental space where people can inject pre‐obtained substances under the supervision of trained staff. This article describes an unusual incident occurring at the Medically Supervised Injecting Centre in January 2023.Case Presentation: Two regular male clients attending the Medically Supervised Injecting Centre injected a substance they believed to be cocaine. Both clients experienced adverse reactions; one was transported to hospital, while the other became extremely distressed and agitated. Paraphernalia sent for testing returned a result of tiletamine (a dissociative used in veterinary medicine) and no cocaine, 30 h after the incident.Discussion and Conclusions: Where substances are novel or unknown, adverse events are often unexpected and may be more difficult to prepare for. Substance‐induced acute agitation can be alarming and hazardous for people consuming drugs and those around them and may pose challenges for staff. There is a substantial evidence base for the benefits of on‐site drug analysis and drug checking in reducing harms related to drug use, and in enhancing drug market monitoring. This incident was successfully managed by Medically Supervised Injecting Centre and hospital staff, with no major consequence, however clinical management could have been improved using point of care drug testing.
- 1 July 2024
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 47 (5) , 1204-1213
Multidisciplinary rehabilitation following recreational nitrous oxide (N 2 O) misuse: evaluating service provision and rehabilitation outcomes in a cohort with serious disability
Purpose: Recreational nitrous oxide (N2O) misuse is increasing globally. Chronic misuse can cause neurological impairments that require rehabilitation, though literature characterising rehabilitation is limited. This study aimed to evaluate rehabilitation service provision for impairments resulting from N2O misuse. Methods: A retrospective audit of hospitalised patients referred for rehabilitation for N2O toxicity was conducted between 2015 and 2022 at a single metropolitan hospital. Data were collected via medical record audit and analysed via descriptive and non-parametric statistics. Results: 16 eligible cases were identified, aged 18-43 years (50% female/male), with increasing case frequency. 12 cases received inpatient rehabilitation episodes for multifactorial sensorimotor, cognitive and psychosocial impairments. Cases articulated diverse rehabilitation goals and received intervention from a median of 6 clinical disciplines. All cases required assistance to mobilise or perform self-care activities on admission. Functional Independence Measure (FIM) scores significantly improved with rehabilitation (median FIM 84[75-93] to 117[112-123], p < .001). Despite gains in independence, all cases required referral for ongoing rehabilitation post-discharge. Conclusions: Demand for inpatient rehabilitation for disabling N2O toxicity appears to be increasing. In this series, cases were young, exhibited serious impairments, and had multidisciplinary rehabilitation needs. Inpatient rehabilitation led to significant functional improvements, though ongoing disability was evident post-discharge.
- 1 July 2024
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 47 (5) , 1204-1213
Multidisciplinary rehabilitation following recreational nitrous oxide (N 2 O) misuse: evaluating service provision and rehabilitation outcomes in a cohort with serious disability
Purpose: Recreational nitrous oxide (N2O) misuse is increasing globally. Chronic misuse can cause neurological impairments that require rehabilitation, though literature characterising rehabilitation is limited. This study aimed to evaluate rehabilitation service provision for impairments resulting from N2O misuse. Methods: A retrospective audit of hospitalised patients referred for rehabilitation for N2O toxicity was conducted between 2015 and 2022 at a single metropolitan hospital. Data were collected via medical record audit and analysed via descriptive and non-parametric statistics. Results: 16 eligible cases were identified, aged 18-43 years (50% female/male), with increasing case frequency. 12 cases received inpatient rehabilitation episodes for multifactorial sensorimotor, cognitive and psychosocial impairments. Cases articulated diverse rehabilitation goals and received intervention from a median of 6 clinical disciplines. All cases required assistance to mobilise or perform self-care activities on admission. Functional Independence Measure (FIM) scores significantly improved with rehabilitation (median FIM 84[75-93] to 117[112-123], p < .001). Despite gains in independence, all cases required referral for ongoing rehabilitation post-discharge. Conclusions: Demand for inpatient rehabilitation for disabling N2O toxicity appears to be increasing. In this series, cases were young, exhibited serious impairments, and had multidisciplinary rehabilitation needs. Inpatient rehabilitation led to significant functional improvements, though ongoing disability was evident post-discharge.
- Open Access
- 23 May 2022
- Published by Wiley in Drug and Alcohol Review
- Vol. 41 (6) , 1322-1330
Barriers to help‐seeking among music festival attendees in New South Wales, Australia
Introduction: Prompt help‐seeking behaviour by music festival attendees can reduce risks associated with drug use; however, little is known about perceived barriers to help‐seeking when experiencing or witnessing illness at music festivals. We explored potential barriers and their association with festivalgoer characteristics.Methods: We conducted an on‐site cross‐sectional survey of attendees at New South Wales music festivals in 2019/2020. Perceived barriers to help‐seeking in the hypothetical event of the respondent or a friend becoming unwell at the festival were assessed, and regression analyses were conducted to identify characteristics associated with these barriers.Results: Across six festivals, 1229 people were surveyed and four‐fifths (83.2%) reported ≥1 barrier: 32.7% fear of getting in trouble with the police, 20.6% not knowing where to find help, 17.2% not knowing how unwell someone might be and 15.3% concern about friends or relatives finding out. In multivariable analyses, people of diverse sexuality and people using drugs that day had greater odds of reporting fear of trouble with the police. People reporting drug use that day had lower odds of reporting not knowing where to find help. Men, gender‐diverse people and people using drugs that day had greater odds of reporting concern about friends or relatives finding out.Discussion and Conclusions: Our data substantiate concerns regarding policing strategies and their impact on festivals. Initiatives to support conversations about drugs with friends and families may be best targeted to younger people and those from gender‐diverse backgrounds.
- 23 May 2022
- Published by Wiley in Drug and Alcohol Review
- Vol. 41 (6) , 1322-1330
Open AccessBarriers to help‐seeking among music festival attendees in New South Wales, Australia
Introduction: Prompt help‐seeking behaviour by music festival attendees can reduce risks associated with drug use; however, little is known about perceived barriers to help‐seeking when experiencing or witnessing illness at music festivals. We explored potential barriers and their association with festivalgoer characteristics.Methods: We conducted an on‐site cross‐sectional survey of attendees at New South Wales music festivals in 2019/2020. Perceived barriers to help‐seeking in the hypothetical event of the respondent or a friend becoming unwell at the festival were assessed, and regression analyses were conducted to identify characteristics associated with these barriers.Results: Across six festivals, 1229 people were surveyed and four‐fifths (83.2%) reported ≥1 barrier: 32.7% fear of getting in trouble with the police, 20.6% not knowing where to find help, 17.2% not knowing how unwell someone might be and 15.3% concern about friends or relatives finding out. In multivariable analyses, people of diverse sexuality and people using drugs that day had greater odds of reporting fear of trouble with the police. People reporting drug use that day had lower odds of reporting not knowing where to find help. Men, gender‐diverse people and people using drugs that day had greater odds of reporting concern about friends or relatives finding out.Discussion and Conclusions: Our data substantiate concerns regarding policing strategies and their impact on festivals. Initiatives to support conversations about drugs with friends and families may be best targeted to younger people and those from gender‐diverse backgrounds.